share_log

SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Chidozie Ugwumba(19.9%)

SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Chidozie Ugwumba(19.9%)

SC 13G/A:超过5%持股股东披露文件(修正)-Chidozie Ugwumba(19.9%)
美股SEC公告 ·  10/02 15:59

Moomoo AI 已提取核心信息

Chidozie Ugwumba has filed an amended Schedule 13G with the Securities and Exchange Commission, disclosing a 19.9% ownership stake in Clene Inc., a biopharmaceutical company. The filing, dated September 30, 2024, indicates that Ugwumba beneficially owns 2,249,661 shares of Clene's common stock, which includes shares issuable upon the exercise of various warrants. The disclosure follows Ugwumba's resignation from Clene's board of directors on February 15, 2023, and asserts that his holding is for investment purposes and not intended to change or influence control of the company. The reported ownership percentage is based on the total number of Clene's shares outstanding as of September 30, 2024, plus additional shares that could be acquired through warrant exercises, subject to a cap that prevents ownership exceeding 19.9% of voting securities.
Chidozie Ugwumba has filed an amended Schedule 13G with the Securities and Exchange Commission, disclosing a 19.9% ownership stake in Clene Inc., a biopharmaceutical company. The filing, dated September 30, 2024, indicates that Ugwumba beneficially owns 2,249,661 shares of Clene's common stock, which includes shares issuable upon the exercise of various warrants. The disclosure follows Ugwumba's resignation from Clene's board of directors on February 15, 2023, and asserts that his holding is for investment purposes and not intended to change or influence control of the company. The reported ownership percentage is based on the total number of Clene's shares outstanding as of September 30, 2024, plus additional shares that could be acquired through warrant exercises, subject to a cap that prevents ownership exceeding 19.9% of voting securities.
Chidozie Ugwumba向美国证券交易委员会提交了修订后的13G表格,披露对Clene Inc.拥有19.9%的股权。该申报文件日期为2024年9月30日,显示Ugwumba有权拥有Clene普通股共2,249,661股,其中包括可以通过行使各类权证而发行的股份。该披露跟随Ugwumba于2023年2月15日辞去Clene董事会职务,声明其持有的股份是出于投资目的,并无意改变或影响公司的控制。所报告的持股百分比基于2024年9月30日Clene已发行股份总数,再加上通过行使权证而可能获得的额外股份,但受限于一项规定,防止持有超过19.9%的表决权证券。
Chidozie Ugwumba向美国证券交易委员会提交了修订后的13G表格,披露对Clene Inc.拥有19.9%的股权。该申报文件日期为2024年9月30日,显示Ugwumba有权拥有Clene普通股共2,249,661股,其中包括可以通过行使各类权证而发行的股份。该披露跟随Ugwumba于2023年2月15日辞去Clene董事会职务,声明其持有的股份是出于投资目的,并无意改变或影响公司的控制。所报告的持股百分比基于2024年9月30日Clene已发行股份总数,再加上通过行使权证而可能获得的额外股份,但受限于一项规定,防止持有超过19.9%的表决权证券。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息